Luntz M H
Adv Ophthalmol. 1978;36:187-96.
Uveitis is divided into five clinical groups based on its severity and natural history. By using this classification appropriate and graded forms of therapy can be applied to individual patients with uveitis. In Group 1 patients (anterior uveitis syndrome) topical cortisone drops or ointment will control the disease. Group 2 (posterior uveitis) patients require local steroids (topical, subconjunctival or retrobulbar) and systemic steroids. Appropriate specific therapies are indicated if a causal organism can be identified. Patients in Groups 3 (cyclitis), Group 4 (uveitis in children) and Group 5 (severe intractable uveitis) are exposed to a high risk of cystic macula degeneration and must be treated with local and systemic cortisone and cytotoxic drugs if the steroid fails to control the inflammation or if cortisone has to be used excessively high dosage. The recommended regime of treatment is summarised in the diagram in figure 7.
葡萄膜炎根据其严重程度和自然病程分为五个临床组。通过使用这种分类方法，可以对个体葡萄膜炎患者应用适当且分级的治疗形式。在第1组患者（前葡萄膜炎综合征）中，局部使用可的松滴眼液或眼膏可控制病情。第2组（后葡萄膜炎）患者需要局部使用类固醇（局部、结膜下或球后注射）和全身使用类固醇。如果能够确定致病微生物，则需要进行适当的特异性治疗。第3组（睫状体炎）、第4组（儿童葡萄膜炎）和第5组（严重难治性葡萄膜炎）的患者发生黄斑囊样变性的风险很高，如果类固醇无法控制炎症或必须使用过高剂量的可的松，则必须使用局部和全身可的松以及细胞毒性药物进行治疗。推荐的治疗方案总结在图7的图表中。
